1 – 32 of 32
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?
(
- Contribution to journal › Article
- 2018
-
Mark
The assessment of nailfold capillaries : Comparison of dermoscopy and nailfold videocapillaroscopy
(
- Contribution to journal › Letter
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
- 2017
-
Mark
Quantitative outcome measures for systemic sclerosis-related Microangiopathy – Reliability of image acquisition in Nailfold Capillaroscopy
(
- Contribution to journal › Article
-
Mark
Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy
(
- Contribution to journal › Article
-
Mark
ESVM guidelines – the diagnosis and management of raynaud’s phenomenon
(
- Contribution to journal › Scientific review
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
-
Mark
Update of EULAR recommendations for the treatment of systemic sclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
- 2014
-
Mark
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
(
- Contribution to journal › Article
- 2013
-
Mark
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
(
- Contribution to journal › Article
-
Mark
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
(
- Contribution to journal › Article
- 2012
-
Mark
Comment on: A multicentre study on the reliability of qualitative and quantitative nailfold videocapillaroscopy assessment: reply.
(
- Contribution to journal › Article
-
Mark
A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment.
(
- Contribution to journal › Article
-
Mark
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor
(
- Contribution to journal › Article
-
Mark
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis.
2012) In Journal of Rheumatology(
- Contribution to journal › Article
-
Mark
A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
(
- Contribution to journal › Article
- 2011
-
Mark
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
(
- Contribution to journal › Article
-
Mark
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
(
- Contribution to journal › Article
-
Mark
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
(
- Contribution to journal › Article
- 2010
-
Mark
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
(
- Contribution to journal › Article
- 2008
-
Mark
MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.622-622(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.822-822(
- Contribution to journal › Published meeting abstract
-
Mark
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
(
- Contribution to journal › Article
-
Mark
Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.821-821(
- Contribution to journal › Published meeting abstract
-
Mark
A large multicenter analysis of CTGF-945 promoter polymorphism does not confirm association with systemic Sclerosis susceptibility or phenotype
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.588-589(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
(
- Contribution to journal › Article